Previous Article | Next Article ![]()
J. Virol., 08 1995, 4814-4822, Vol 69, No. 8
JC Pugh, Q Di, WS Mason and H Simmons
To test the hypothesis that susceptibility of hepatocytes to duck hepatitis
B virus (DHBV) infection requires cell surface receptors that bind the
virus in a specific manner, we developed an assay for the binding of DHBV
particles to monolayers of intact cells, using radiolabeled immunoglobulin
G specific for DHBV envelope protein. Both noninfectious DHBV surface
antigen particles and infectious virions bound to a susceptible fraction
(approximately 60%) of Pekin duck hepatocytes. In contrast, binding did not
occur to cells that were not susceptible to DHBV infection, including Pekin
duck fibroblasts and chicken hepatocytes, and binding to Muscovy duck
hepatocytes, which are only weakly susceptible (approximately 1% of cells)
to DHBV infection, was virtually undetectable. Within a monolayer,
individual Pekin duck hepatocytes appeared to differ markedly in the
capacity to bind DHBV, which may explain difficulties that have been
encountered in infecting 100% of cells in culture. We have also found that
the loss of susceptibility to infection with DHBV that occurs when Pekin
duck hepatocytes are maintained for more than a few days in culture
correlates with a decline in the number of cells that bind virus particles
efficiently. All of these results support the interpretation that the
binding event detected by our assay is associated with the interaction
between DHBV and specific cell surface receptors that are required for
initiation of infection. Our assay may facilitate isolation and
identification of hepatocyte receptors for this virus.
Copyright © 1995, American Society for Microbiology
Susceptibility to duck hepatitis B virus infection is associated with the presence of cell surface receptor sites that efficiently bind viral particles
Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|